Immigrant adults with liver cancer in the United States have higher survival rates than people with the disease who were born in the U.S., according to new research from the USC Norris Comprehensive Cancer Center. Immigrants comprise a significant proportion of those diagnosed with hepatocellular carcinoma in the U.S. Research has shown that birthplace, also referred to as nativity, impacts incidence and risk factors for HCC, but little was known about its influence on survival after diagnosis. The new study, just published in the Journal of the National Cancer Institute, identified a previously unrecognized disparity in survival after a diagnosis of liver cancer across all major racial/ethnic groups, with immigrants having better survival compared to those born in the U.S.